Bridgeway Capital Management, LLC Seres Therapeutics, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.75 - $1.56 $112,500 - $234,000	150,000 New	150,000 $115,000
Q2 2020 Aug 14, 2020	SELL	$3.04 - $6.2 $219,184 - $447,020	-72,100 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.64 - $3.82 $190,344 - $275,422	72,100 New	72,100 $257,000
Q4 2019 Feb 14, 2020	SELL	$2.99 - $4.42 $456,274 - $674,492	-152,600 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.29 - $4.16 $16,259 - $29,536	7,100 Added 4.88%	152,600 $612,000
Q1 2019 May 15, 2019	BUY	$4.83 - $7.21 $702,765 - $1.05 Million	145,500 New	145,500 $1 Million

46.7M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $102M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.